Researchers Discover Potential New Treatment for ALS

Two researchers affiliated with Northwestern University have discovered a new drug that may outperform existing treatments for amyotrophic lateral sclerosis (ALS). The drug, NU-9, was created with a novel mechanism that will require extensive testing before being deemed safe for large-scale human trials. Findings were published in Nature earlier this year, with hopes to advance the drug in a clinical setting within the upcoming years.